PHAXIAM Therapeutics S.A.
Related Filers (4)
- BIOTECHNOLOGY VALUE FUND L P (11)
- BANK OF NEW YORK / ADR DIVISION (3)
- BAKER BROS. ADVISORS LP (3)
- ARMISTICE CAPITAL, LLC (2)
- Show More ...
Other (133)
6-K
Friday, 1/19/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/25/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 9/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/18/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 9/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/7/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CB
Wednesday, 5/24/2023
Notification form filed in connection with certain tender offers, business combinations and rights offerings, in which the subject company is a foreign private issuer of which less than 10% of its securities are held by U.S. persons
6-K
Wednesday, 5/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-X
Wednesday, 5/24/2023
For appointment of agent for service of process by issuers registering securities
6-K
Tuesday, 5/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/18/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Tuesday, 3/28/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Thursday, 3/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/12/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K/A
Monday, 9/12/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/25/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/25/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/2/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 4/27/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Monday, 4/25/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/15/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/10/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 1/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 12/16/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/30/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/16/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/25/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/5/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Wednesday, 9/29/2021
Notice of Effectiveness
CORRESP
Tuesday, 9/28/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Tuesday, 9/21/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3
Tuesday, 9/21/2021
Registration statement for specified transactions by certain foreign private issuers
6-K
Monday, 9/20/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/30/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/26/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/29/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CT ORDER
Tuesday, 6/15/2021
Order Granting Confidential Treatment
6-K
Wednesday, 5/26/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/7/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/3/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/3/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/21/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 4/19/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/9/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Monday, 3/8/2021
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Monday, 2/8/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/27/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 1/15/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/15/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 12/7/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/6/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/3/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Friday, 10/9/2020
Notice of Effectiveness
F-3/A
Thursday, 10/8/2020
Registration statement for specified transactions by certain foreign private issuers
F-3/A
Wednesday, 10/7/2020
Registration statement for specified transactions by certain foreign private issuers
CORRESP
Wednesday, 10/7/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Tuesday, 9/22/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/21/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3
Monday, 9/21/2020
Registration statement for specified transactions by certain foreign private issuers
6-K
Tuesday, 9/15/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/26/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/25/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/9/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/2/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/26/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/8/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/30/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/21/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 3/18/2020
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Tuesday, 3/17/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/6/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/8/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/26/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/18/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Tuesday, 7/30/2019
Notice of Effectiveness
CORRESP
Monday, 7/29/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3
Tuesday, 7/16/2019
Registration statement for specified transactions by certain foreign private issuers
6-K
Tuesday, 7/16/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/26/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/25/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/7/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Ownership (16)
SC 13G/A
Tuesday, 2/14/2023
ARMISTICE CAPITAL, LLC: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Friday, 12/23/2022
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G
Tuesday, 2/15/2022
ARMISTICE CAPITAL, LLC: Major Shareholders
SC 13G/A
Monday, 2/14/2022
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G
Wednesday, 3/10/2021
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13D/A
Friday, 1/29/2021
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13D/A
Tuesday, 1/12/2021
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13D/A
Tuesday, 10/13/2020
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13D/A
Thursday, 11/8/2018
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13D/A
Thursday, 11/8/2018
BAKER BROS. ADVISORS LP: Major Shareholders
SC 13D
Thursday, 7/19/2018
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13D/A
Monday, 7/2/2018
BAKER BROS. ADVISORS LP: Major Shareholders
SC 13G/A
Monday, 7/2/2018
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G
Tuesday, 1/2/2018
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13D
Thursday, 11/16/2017
BAKER BROS. ADVISORS LP: Major Shareholders
Prospectus (22)
424B3
Thursday, 6/29/2023
Prospectus filed pursuant to Rule 424(b)(3)
S-8
Thursday, 6/30/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Thursday, 12/16/2021
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Friday, 5/7/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Wednesday, 5/5/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 5/3/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 10/9/2020
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Thursday, 6/25/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B3
Tuesday, 7/30/2019
Prospectus filed pursuant to Rule 424(b)(3)
S-8
Tuesday, 7/16/2019
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Wednesday, 1/24/2018
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
FWP
Monday, 11/13/2017
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B4
Monday, 11/13/2017
Prospectus filed pursuant to Rule 424(b)(4)
FWP
Thursday, 11/9/2017
Filing under Securities Act Rules 163/433 of free writing prospectuses
DRS/A
Monday, 7/10/2017
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS/A
Friday, 3/25/2016
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Friday, 3/25/2016
Correspondence Related to Draft Registration Statement
DRS/A
Friday, 10/23/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Friday, 10/23/2015
Correspondence Related to Draft Registration Statement
DRS/A
Tuesday, 9/8/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Tuesday, 9/8/2015
Correspondence Related to Draft Registration Statement
DRS
Monday, 7/27/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy